|Articles|October 22, 2020
Advancing E&L Detection by Pharma Manufacturers
Author(s)SGS
Coupling a headspace sampling technique with a HRAM GC-MS system provides quick assessments and quantifies potentially dangerous, untargeted volatile extractables
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
2
PharmTech Weekly News Roundup – Week of January 26, 2026
3
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
4
Vetter Announces Plan to Build Manufacturing Site in Germany with €1.5 Billion CDMO Investment
5